Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 4/20 | 0.59 |
| ▸ | AURKA | O14965 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP10 | P09238 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | PRKACA | P17612 | 1/20 | 0.50 |
| ▸ | DRD5 | P21918 | 1/20 | 0.50 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.50 |
| ▸ | MMP14 | P50281 | 1/20 | 0.50 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1314036 | 0.78 | MMP13 (0.55) | MMP13 | |
| SCHEMBL1316043 | 0.74 | MMP13 (1.00) | MMP13AURKAMMP2MMP10MMP9 | |
| SCHEMBL1316395 | 0.72 | MMP13 (0.73) | MMP13AURKAMMP2MMP10MMP9 | |
| SCHEMBL1313634 | 0.69 | MMP13 (1.00) | MMP13AURKAMMP2MMP10MMP9 | |
| SCHEMBL15888040 | 0.69 | MMP13 (0.54) | MMP13MMP2MMP14 | |
| SCHEMBL1313851 | 0.68 | MMP13 (0.68) | MMP13 | |
| Bi 4394 SCHEMBL1314835 | 0.67 | MMP13 (1.00) | MMP13AURKAMMP2MMP10MMP9 | |
| SCHEMBL1313998 | 0.66 | MMP13 (0.59) | MMP13AURKAMMP2MMP10MMP9 | |
| SCHEMBL28954653 | 0.66 | NAMPT (0.78) | — | |
| SCHEMBL1316251 | 0.66 | MMP13 (0.60) | MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2340243-B1 | HETEROARYL SUBSTITUTED INDOLE COMPOUNDS USEFUL AS MMP-13 INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2014-10-08 | — | — | EP | disclosed |